Advertisement

Author: Rylee Wilson

Wegovy is now approved to be used to reduce the risk of heart attack, stroke and cardiovascular death, which could lead to broader payer coverage of the drug. 

Medicare Part D plans have ramped up restrictions on prescription drugs since 2011, a study published in the March edition of Health Affairs found. 

Advertisement
Advertisement